Literature DB >> 18996392

E2-c-Cbl recognition is necessary but not sufficient for ubiquitination activity.

Anding Huang1, Rob N de Jong, Hans Wienk, G Sebastiaan Winkler, H Th Marc Timmers, Rolf Boelens.   

Abstract

The E2 ubiquitin-conjugating enzymes UbcH7 and UbcH5B both show specific binding to the RING (really interesting new gene) domain of the E3 ubiquitin-protein ligase c-Cbl, but UbcH7 hardly supports ubiquitination of c-Cbl and substrate in a reconstituted system. Here, we found that neither structural changes nor subtle differences in the E2-E3 interaction surface are possible explanations for the functional specificity of UbcH5B and UbcH7 in their interaction with c-Cbl. The quick transfer of ubiquitin from the UbcH5B-Ub thioester to c-Cbl or other ubiquitin acceptors suggests that UbcH5B might functionally be a relatively pliable E2 enzyme. In contrast, the UbcH7-Ub thioester is too stable to transfer ubiquitin under our assay conditions, indicating that UbcH7 might be a more specific E2 enzyme. Our results imply that the interaction specificity between c-Cbl and E2 is required but not sufficient for transfer of ubiquitin to potential targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996392     DOI: 10.1016/j.jmb.2008.10.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.

Authors:  Sarah E Soss; Yuanyuan Yue; Sirano Dhe-Paganon; Walter J Chazin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.

Authors:  Maritza Lienlaf; Fumiaki Hayashi; Francesca Di Nunzio; Naoya Tochio; Takanori Kigawa; Shigeyuki Yokoyama; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

3.  Recognition of UbcH5c and the nucleosome by the Bmi1/Ring1b ubiquitin ligase complex.

Authors:  Matthew L Bentley; Jacob E Corn; Ken C Dong; Qui Phung; Tommy K Cheung; Andrea G Cochran
Journal:  EMBO J       Date:  2011-07-19       Impact factor: 11.598

4.  Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.

Authors:  Rebecca Feltham; Bodhi Bettjeman; Rhesa Budhidarmo; Peter D Mace; Sarah Shirley; Stephen M Condon; Srinivas K Chunduru; Mark A McKinlay; David L Vaux; John Silke; Catherine L Day
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

Review 5.  Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination.

Authors:  Mehmet Gundogdu; Helen Walden
Journal:  Protein Sci       Date:  2019-08-23       Impact factor: 6.725

Review 6.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

7.  RING domain dimerization is essential for RNF4 function.

Authors:  Chu Wai Liew; Huaiyu Sun; Tony Hunter; Catherine L Day
Journal:  Biochem J       Date:  2010-10-01       Impact factor: 3.857

8.  Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.

Authors:  Alexander Espinosa; Janosch Hennig; Aurélie Ambrosi; Madhanagopal Anandapadmanaban; Martina Sandberg Abelius; Yi Sheng; Filippa Nyberg; Cheryl H Arrowsmith; Maria Sunnerhagen; Marie Wahren-Herlenius
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

9.  Ubiquitin in motion: structural studies of the ubiquitin-conjugating enzyme∼ubiquitin conjugate.

Authors:  Jonathan N Pruneda; Kate E Stoll; Laura J Bolton; Peter S Brzovic; Rachel E Klevit
Journal:  Biochemistry       Date:  2011-02-21       Impact factor: 3.162

10.  The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.

Authors:  Li Zhang; Louise Fairall; Benjamin T Goult; Anna C Calkin; Cynthia Hong; Christopher J Millard; Peter Tontonoz; John W R Schwabe
Journal:  Genes Dev       Date:  2011-06-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.